Skip to main content
Rheumatology Advances in Practice logoLink to Rheumatology Advances in Practice
. 2020 Jul 7;4(2):rkaa030. doi: 10.1093/rap/rkaa030

The presentation, diagnosis and management of non-traumatic wrist pain: an evaluation of current practice in secondary care in the UK NHS

The MOWP study group:
PMCID: PMC7566494  PMID: 33094215

Abstract

Objectives

The study aims were to assess the burden of non-traumatic wrist pain in terms of numbers of referrals to secondary care and to characterize how patients present, are diagnosed and are managed in secondary care in the UK National Health Service.

Methods

Ten consecutive patients presenting with non-traumatic wrist pain were identified retrospectively at each of 16 participating hospitals, and data were extracted for 12 months after the initial referral.

Results

The 160 patients consisted of 100 females and 60 males with a median age of 49 years, accounting for ∼13% of all new hand/wrist referrals. The dominant wrist was affected in 60% of cases, and the mean symptom duration was 13.3 months. Diagnoses were grouped as follows: OA (31%), tendinopathy (13%), ganglion (14%), ulnar sided pain (17%) and other (25%). The OA group was significantly older than other groups, and other groups contained a predominance of females. The non-surgical interventions, in decreasing frequency of usage, were as follows: CS injections (39%), physiotherapy (32%), splint (31%) and analgesics (12%). Of those who underwent surgery, all patients had previously received non-surgical treatment, but 42% had undergone only one non-surgical intervention.

Conclusions

Non-traumatic wrist pain represents a significant burden to secondary care both in terms of new patient referrals and in terms of investigation, follow-up and treatment. Those presenting with OA are more likely to be older and male, whereas those presenting with other diagnoses are more likely to be younger and female.

Keywords: wrist, pain, osteoarthritis, surgery, National Health Service


Key messages

  • Non-traumatic wrist pain represents a significant burden to secondary care in the UK.

  • The most common diagnostic group was OA of the wrist.

  • The most widely used non-surgical intervention was the CS injection.

Introduction

Wrist pain is a common problem, accounting for an annual consultation prevalence rate of 58 in 10 000 patients in primary care in the UK [1]; ∼1/10th of the consultation rate for back pain, the most common site of musculoskeletal pain. The prevalence of non-specific hand and wrist pain is ∼10% in the general population [2], higher than the combined total prevalence of de Quervain’s tenosynovitis, wrist tenosynovitis and carpal tunnel syndrome reported at ∼3%. Wrist pain is more prevalent in those who work in more physically demanding occupations and in sportspeople [3].

The variable structure of local health-care systems within the National Health Service (NHS) in the UK means that pathways for non-traumatic wrist pain are likely to be heterogeneous [4]. Generally, referrals pass from primary care, through an interface musculoskeletal service for initial diagnostics and treatment, with secondary care referrals emerging as necessary. Relatively little has been published regarding the presentation, diagnosis and management of non-traumatic wrist pain in both interface and secondary care services.

In this context, the specific aims of this study were to assess the overall proportion of referrals for non-traumatic wrist pain received by specialist hand and wrist clinics in the UK, to describe the demographics and diagnoses in these patients and to describe the investigations and interventions performed.

Methods

Ten consecutive patients presenting with non-traumatic wrist pain were identified from specialist hand and wrist clinics in 16 UK hospitals. Data collection was performed collaboratively, using orthopaedic higher surgical trainees and consultants (invited via the British Orthopaedic Network Environment) and informal, regional consultant networks. No hospitals were excluded. Data gathering was approved via the audit department of each participating hospital.

Patients were identified retrospectively by reviewing all new patient referrals from 1 January 2017 onwards. Patients with a clear history or radiological evidence of substantial trauma were excluded (i.e. scaphoid fracture or non-union/distal radius fracture or malunion/fracture clinic patients), as were patients with previous wrist surgery to the affected side, diagnosis of inflammatory arthritis, a suspected diagnosis of carpal tunnel syndrome, thumb base degeneration or patients referred by another hand/wrist specialist for a second/third opinion. Fig. 1 summarizes the patient selection process.

Fig. 1.

Fig. 1

Flow diagram demonstrating patient selection process

The first 10 patients presenting with non-traumatic wrist pain were reviewed in detail from first appointment through to discharge or to 12 months after the initial appointment, whichever occurred first. The total number of new patient referrals required to obtain 10 non-traumatic wrist pains was recorded. Data were collected using a standardized form, including age, biological sex, hand dominance, employment status, date of first appointment, site of wrist pain, duration of symptoms, investigations undertaken, non-surgical interventions undertaken, final stated diagnosis, date and type of surgery, complications, the number of appointments over the 1 year period and whether the patient had been discharged by the end of this year. If diagnostic uncertainty remained at the end of follow-up, this was recorded as unknown. The data related to the clinical documentation only. Thus, if use of analgesia had not been documented specifically, for the purposes of this study it did not occur.

Five broad diagnostic categories were generated by consensus involving the senior surgeons within the group (N.R. and R.W.T.) before data analysis: OA, including radiocarpal, midcarpal or distal radioulnar joint; tendinopathy; ulnar sided pain, including ulnocarpal abutment, triangular fibrocartilage and extensor carpi ulnaris pathology; ganglion; and other (non-traumatic instability, avascular necrosis, non-specific and unknown).

Statistics

Statistical analysis was carried out using GraphPad Prism v.5.00 for Windows (GraphPad Software, San Diego, CA, USA; www.graphpad.com) and with STATA/IC v.16 (StataCorp LP, College Station, TX, USA). Histograms for all data sets were analysed to assess for normality. Data were normally distributed unless stated otherwise. Results are expressed as the mean (s.d.) unless stated otherwise. Student’s unpaired t-tests and Mann–Whitney U-tests were used to test for differences between two groups for parametric and non-parametric data, respectively. The Kruskal–Wallis one-way ANOVA was used to test for differences within multiple groups of non-parametric data, and ANOVA was used to test multiple groups of parametric data. Fisher’s exact test was used to test for differences between two categorical variables. Statistical significance was set at a level of P < 0.05.

Results

Centres, referral patterns and burden

The details relating to the 16 participating centres are presented in Supplementary Table S1. The mean proportion of hand and wrist clinic referrals that related to non-traumatic wrist pain was 12.9% over a mean 106-day review period. Using this proportion, correcting for the observed 106-day review period and assuming a UK population of 66 million, there are ∼4228 new patient referrals to secondary care for non-traumatic wrist pain per annum in the UK (Fig. 1).

Patient demographics and characteristics

There were 100 females and 60 males, with a median age of 49 (interquartile range 34–60) years. The dominant wrist was affected in 60% of cases, and the mean symptom duration was 13.3 months. OA of the radiocarpal or midcarpal joints was the most common diagnosis within the nine categories considered (Table 1). A further breakdown of the diagnoses within each diagnostic group is detailed in Supplementary Table S2.

Table 1.

Breakdown of patient demographics and characteristics based on gender

Factor Level All Male Female P-value (between male and female)
n 160 60 100
Age, median (interquartile range), years 49.0 (34.0–60.0) 54.5 (34.0–68.5) 47.5 (33.0–54.0) 0.035*
Wrist affected, n (%) Dominant 96 (60.0) 33 (55.0) 63 (63.0) 0.47
Non-dominant 52 (32.5) 23 (38.3) 29 (29.0)
Both 12 (7.5) 4 (6.7) 8 (8.0)
Diagnosis, n (%) OA 49 (30.6) 34 (56.7) 15 (15) <0.001***
Ulnar group 28 (17.5) 7 (11.7) 21 (21.0)
Tendinopathy 21 (13.1) 4 (6.7) 17 (17.0)
Ganglion 22 (13.8) 2 (3.3) 20 (20.0)
Other 40 (25) 13 (21.7) 27 (27)
Symptom duration, mean (s.d.), months 13.3 (11.3) 14.4 (12.4) 12.6 (10.6) 0.33
Site of wrist pain, n (%) Ulnar 46 (28.7) 19 (31.7) 27 (27.0) 0.50
Radial 47 (29.4) 18 (30.0) 29 (29.0)
Central 39 (24.4) 16 (26.7) 23 (23.0)
Diffuse 28 (17.5) 7 (11.7) 21 (21.0)
Employment, n (%) Unemployed 12 (7.5) 1 (1.7) 11 (11.0) 0.032*
Employed 92 (57.5) 39 (65.0) 53 (53.0)
Retired 27 (16.9) 13 (21.7) 14 (14.0)
Unknown 29 (18.1) 7 (11.7) 22 (22.0)

***P-value < 0.001, **P-value < 0.01, *P-value < 0.05.

Patients with a diagnosis of OA were significantly older (median age 64 years) than other groups (median ages between 41 and 44 years) and contained a statistically significant predominance of males (69%, P < 0.001; Table 2). There was a similar proportion of dominant (49%) and non-dominant (45%) wrists affected. In comparison, the other diagnostic groups were predominantly female (between 67 and 91%), with the dominant wrist affected (between 57 and 73%; P = 0.09).

Table 2.

Breakdown of patient demographics and characteristics based on the five diagnostic groups

Factor Level OA Tendinopathy Ganglion Ulnar group Other P-value
Number of patients, n (%) 49 (31) 21 (13) 22 (14) 28 (17) 40 (25)
Age, median (interquartile range), years 64.0 (53.0–73.0) 44.0 (37.0–54.0) 41.0 (27.0–53.0) 44.0 (32.0–51.0) 44.0 (30.0–52.0) <0.001***
Sex, n (%) Male 34 (69) 4 (19) 2 (9) 7 (25) 13 (33) <0.001***
Female 15 (31) 17 (81) 20 (91) 21 (75) 27 (68)
Wrist affected, n (%) Dominant 24 (49) 13 (62) 16 (73) 16 (57) 27 (68) 0.089
Non-dominant 22 (45) 4 (19) 6 (27) 11 (39) 9 (23)
Both 3 (6) 4 (19) 0 (0) 1 (4) 4 (10)
Symptom duration, mean (s.d.), months 13.8 (10.9) 11.5 (10.3) 11.4 (7.1) 15.6 (12.5) 13.1 (13.3) 0.66
Site, n (%) Ulnar 12 (24) 0 (0) 2 (9) 23 (82) 9 (23) <0.001***
Radial 18 (37) 18 (86) 3 (14) 1 (4) 7 (18)
Central 10 (20) 3 (14) 10 (45) 1 (4) 15 (38)
Diffuse 9 (18) 0 (0) 7 (32) 3 (11) 9 (23)
Employed, n (%) Unemployed 5 (10) 1 (5) 2 (9) 1 (4) 3 (8) 0.012*
Employed 21 (43) 11 (52) 11 (50) 21 (75) 28 (70)
Retired 17 (35) 2 (10) 3 (14) 3 (11) 2 (5)
Unknown 6 (12) 7 (33) 6 (27) 3 (11) 7 (18)
Instability, n (%) No 45 (92) 21 (100) 22 (100) 27 (96) 33 (83) 0.11
Yes 4 (8) 0 (0) 0 (0) 1 (4) 7 (18)

***P-value < 0.001, **P-value < 0.01, *P-value < 0.05.

Investigations and clinical follow-up

There were statistically significant differences between diagnostic groups and investigations obtained (Table 3). Plain radiographs were the most commonly obtained investigation overall (89%) and used most frequently where an eventual diagnosis of OA was made (98%). MRI was frequently used for patients with ulnar sided (82%) and other pathology (60%) groups. US was used in 21% of patients overall and was used most frequently in tendinopathy (57%) and ganglia (32%). Use of MRI but not US was associated with a significant likelihood of being discharged within the year (P = 0.003). Not having an X-ray was positively associated with being discharged (P = 0.0001). Neither of those diagnostic modalities was associated with a decreased need for surgery (P = 0.3). Nerve conduction studies were used infrequently (8% overall). The median number of appointments within the 12-month period was two, with most patients having two or more appointments within the year (84%). Having more than two appointments was significantly associated with risk of having surgery (P = 0.0001). The proportion discharged by the end of the 12-month period was significantly different between diagnostic groups, with the group most likely to be discharged being tendinopathy (76%) and the least likely patients with ulnar sided pain (32%).

Table 3.

Details of investigations and non-surgical interventions undertaken

Factor Level Overall OA Tendinopathy Ganglion Ulnar group Other P-value
Number of patients 160 49 21 22 28 40
Investigations, n (%)
 X-ray No 17 (11) 1 (2) 8 (38) 6 (27) 2 (7) 3 (8) <0.001***
Yes 143 (89) 48 (98) 13 (62) 16 (73) 26 (93) 37 (93)
 US No 126 (79) 47 (96) 9 (43) 15 (68) 24 (86) 31 (79) <0.001***
Yes 34 (21) 2 (4) 12 (57) 7 (32) 4 (14) 9 (22)
 Nerve conduction study No 147 (92) 49 (100) 21 (100) 19 (86) 27 (96) 31 (78) <0.001***
Yes 13 (8) 0 (0) 0 (0) 3 (14) 1 (4) 9 (23)
 MRI No 89 (56) 33 (67) 19 (90) 16 (73) 5 (18) 16 (40) <0.001***
Yes 71 (44) 16 (33) 2 (10) 6 (27) 23 (82) 24 (60)
Non-surgical, n (%)
 Analgesia No 140 (88) 39 (80) 18 (86) 21 (95) 25 (89) 37 (93) 0.27
Yes 20 (12) 10 (20) 3 (14) 1 (5) 3 (11) 3 (8)
 Physical therapy No 109 (68) 32 (65) 17 (81) 21 (95) 18 (64) 21 (54) 0.01*
Yes 51 (32) 17 (35) 4 (19) 1 (5) 10 (36) 19 (46)
 Splint No 110 (69) 25 (51) 16 (76) 20 (91) 22 (79) 27 (68) 0.007**
Yes 50 (31) 24 (49) 5 (24) 2 (9) 6 (21) 13 (33)
 Injection No 97 (61) 25 (51) 9 (43) 15 (68) 17 (61) 31 (78) 0.041*
Yes 63 (39) 24 (49) 12 (57) 7 (32) 11 (39) 9 (23)
 Any treatment 0 30 (23) 3 (6) 5 (24) 6 (27) 8 (29) 8 (21) 0.080
1 130 (77) 46 (94) 16 (76) 16 (73) 20 (71) 32 (79)
 Number of non-surgical treatments 0 30 (19) 3 (6) 5 (24) 6 (27) 8 (29) 8 (21) 0.14
1 52 (33) 19 (39) 9 (43) 12 (55) 7 (25) 15 (38)
2 46 (29) 16 (33) 3 (14) 4 (18) 9 (32) 14 (36)
3 14 (9) 8 (16) 3 (14) 0 (0) 2 (7) 1 (3)
4 7 (4) 2 (4) 1 (5) 0 (0) 2 (7) 2 (5)
5 1 (1) 1 (2) 0 (0) 0 (0) 0 (0) 0 (0)
 Number of appointments 0 1 (1) 1 (2) 0 (0) 0 (0) 0 (0) 0 (0) 0.40
1 34 (21) 11 (22) 5 (24) 7 (32) 2 (7) 9 (23)
2 65 (41) 19 (39) 12 (57) 10 (45) 11 (39) 13 (33)
3 39 (24) 12 (24) 3 (14) 5 (23) 10 (36) 9 (23)
4 20 (13) 5 (10) 1 (5) 0 (0) 5 (18) 9 (23)
5 1 (1) 1 (2) 0 (0) 0 (0) 0 (0) 0 (0)
 Discharged with the first 12 months No 81 (51) 28 (57) 5 (24) 9 (41) 19 (68) 20 (50) 0.026*
Yes 79 (49) 21 (43) 16 (76) 13 (59) 9 (32) 20 (50)

***P-value < 0.001, **P-value < 0.01, *P-value < 0.05.

Non-surgical interventions

Non-surgical interventions included CS injections (39%), physiotherapy (32%), splint (31%) and analgesics (12%) (Table 3). Splints were used variably between diagnostic groups and most frequently in OA (49%). Physiotherapy was used differently between diagnostic groups (P = 0.01) and most frequently in the other group (49%). Forty-three per cent of patients were treated with two or more non-surgical interventions. Of the 51 patients receiving physiotherapy, the most common regimen was strengthening (14 patients) and unspecified (14 patients); the other regimens were as follows: activity modification (nine patients), range of motion exercises (five patients), strengthening and activity modification (three patients), splint and activity modification (two patients), splint and range of motion exercise (two patients), splint/activity modification/strengthening (one patient) and manual therapy/activity modification/range of motion exercises (one patient).

Surgery and risk factors for surgery

Overall, 27% of patients underwent surgical intervention. In 17 of these 43 patients, a component of the primary surgery was diagnostic. The proportion of diagnostic surgery was significantly different between diagnostic groups (P = 0.002), with diagnostic surgery being most frequent in the ulnar sided (20%) and other (25%) groups (Table 4).

Table 4.

Details of surgery undertaken within the different diagnostic groups

Factor Level Overall OA Tendinopathy Ganglion Ulnar group Other P-value
Number of patients 43 13 4 9 9 8
Surgery, n (%) No 117 (73) 36 (73) 17 (81) 13 (59) 19 (68) 32 (80) 0.38
Yes 43 (27) 13 (27) 4 (19) 9 (41) 9 (32) 8 (20)
Diagnostic surgery, n (%) No 143 (89) 47 (96) 21 (100) 22 (100) 32 (80) 21 (75) 0.002**
Yes 17 (11) 2 (4) 0 (0) 0 (0) 8 (20) 7 (25)
Secondary surgery, n (%) No 38 (88) 11 (85) 4 (100) 9 (100) 7 (78) 7 (88) 0.19
Yes 5 (12) 2 (15) 0 (0) 0 (0) 2 (22) 1 (12)
Complications, n (%) No 38 13 (100) 4 (100) 9 (100) 5 (56) 7 (88) 0.056
Yes 5 (12) 0 (0) 0 (0) 0 (0) 4 (44) 1 (12)
Type of primary surgery, n (%) Arthroscopy 9 3 (23) 0 (0) 0 (0) 4 (44) 2 (25) <0.001***
Arthrodesis 4 4 (31) 0 (0) 0 (0) 0 (0) 0 (0)
Arthroplasty including excision 4 4 (31) 0 (0) 0 (0) 0 (0) 0 (0)
Tendon decompression or debridement 5 0 (0) 4 (100) 0 (0) 1 (11) 0 (0)
Ganglion excision 9 0 (0) 0 (0) 9 (100) 0 (0) 0 (0)
Soft tissue reconstruction 4 0 (0) 0 (0) 0 (0) 0 (0) 4 (50)
Bone grafting 2 0 (0) 0 (0) 0 (0) 1 (11) 1 (13)
Osteotomy, ulnar 3 0 (0) 0 (0) 0 (0) 3 (33) 0 (0)
Other 3 2 (15) 0 (0) 0 (0) 0 (0) 1 (13)
Type of secondary surgery, n (%) Arthrodesis 3 1 (50) 1 (50) 1 (100) 0.71
Other 1 (50) 1 (50)

***P-value < 0.001, **P-value < 0.01, *P-value < 0.05.

Surgery was less likely in patients who had not received non-surgical treatments (P = 0.002; Table 5). There was no association between CS injection and subsequent surgery. There were five complications of surgery (one infection, two failed bone grafting, one instability and one broken screw), of which three required secondary surgery (one failed bone graft converted to arthrodesis, one removal of broken screw and one thumb basal joint stabilization after Brunelli procedure). The other two cases of secondary surgery consisted of arthrodesis after diagnostic arthroscopies.

Table 5.

The relationship between surgery and investigations/interventions

Factor Level No Yes P-value
Surgery, n 117 43
US, n (%) No 92 (80.0) 33 (76.7) 0.65
Yes 23 (20.0) 10 (23.3)
MRI, n (%) No 66 (56.9) 22 (51.2) 0.52
Yes 50 (43.1) 21 (48.8)
X-ray, n (%) No 14 (12.0) 6 (14.0) 0.74
Yes 103 (88.0) 37 (86.0)
Nerve conduction study, n (%) No 105 (89.7) 42 (97.7) 0.10
Yes 12 (10.3) 1 (2.3)
Number of investigations, mean (s.d.) 1.6 (0.8) 1.6 (0.7) 0.80
Analgesia, n (%) No 103 (88.0) 37 (86.0) 0.74
Yes 14 (12.0) 6 (14.0)
Therapy, n (%) No 78 (67.2) 31 (72.1) 0.56
Yes 38 (32.8) 12 (27.9)
Injection, n (%) No 67 (57.3) 30 (69.8) 0.15
Yes 50 (42.7) 13 (30.2)
Splint, n (%) No 77 (65.8) 33 (76.7) 0.19
Yes 40 (34.2) 10 (23.3)
Number of non-surgical treatments, n (%) 0 30 (25.9) 0 (0.0) 0.002**
1 44 (37.9) 18 (41.9)
2 31 (26.7) 15 (34.9)
3 8 (6.9) 5 (11.6)
4 3 (2.6) 4 (9.3)
5 0 (0.0) 1 (2.3)

***P-value < 0.001, **P-value < 0.01, *P-value < 0.05.

Discussion

Like post-traumatic wrist pain [5, 6], based the findings from this sample it appears that non-traumatic wrist pain represents a significant demand on secondary care services regarding new patient referrals and the burden of investigations, follow-up and treatment. These patients generate costs to the health service in terms of investigations (44% undergo an MRI scan), non-surgical treatments, clinic time and surgery (27% undergo some form of surgical intervention).

Perhaps unsurprisingly, those patients ultimately diagnosed with OA were more likely to be older and male, whereas those having other non-osteoarthritic diagnoses were more likely to be younger and female. This is consistent with previous epidemiological research [7, 8].

Many structural abnormalities have been demonstrated to be highly prevalent in asymptomatic patients, such as those relating to the triangular fibrocartilage [9], extensor carpi ulnaris tendon [10] and ganglia [11, 12]. Given the lack of real-world data relating to commonly presenting wrist pain conditions, our study findings detailing the main diagnostic groups are of interest [OA (31%), tendinopathy (13%), ganglion (14%), ulnar including abutment/triangular fibrocartilage (18%) and other (25%)]. Given the absence of high-quality evidence relating to common wrist disorders, this points to the importance of generating high-quality evidence in order to guide practice better in this area, particularly relating to wrist OA [3]. Having an MRI scan, which was most often used for ulnar side pain, was associated with discharge within the first year.

Of those who underwent surgery, all patients had previously received non-surgical treatment, but 42% underwent only one non-surgical treatment, with the remainder being treated with two or more non-surgical therapies. This demonstrates that most patients are undergoing a reasonable course of non-surgical management before converting to a surgical option. It is notable that only 12% of patients were documented to have trialled analgesia and, although this figure is likely to be a significant underestimate of the real proportion of patients taking analgesics. In the context of the Montgomery ruling it is vital to document adequately the non-surgical interventions, such as analgesia, particularly in those undergoing surgical intervention [13].

There are limitations to this work. The methods of sampling used have resulted in potential biases; for example, the sample of hospitals might not be fully representative of the UK, and this might have had some influence on the results. The data have come from sources that rely on clear and complete documentation and are therefore exposed to potential inaccuracies. For the purpose of the analyses, we have grouped the diagnoses into broad categories, and there will be debate that this categorization could have been undertaken differently. Furthermore, given the lack of high-quality studies investigating diagnostic accuracy around the wrist, it cannot be claimed that our decision to take the final stated diagnosis as accurate is free of limitations. However, we feel that this is a pragmatic decision, serving as a sensible starting point upon which further research can be based. Given the paucity of published real-world data relating to non-traumatic wrist pain, this study provides genuinely novel information with significant clinical meaning.

Conclusions

Non-traumatic wrist pain represents a significant burden to secondary care, both in terms of new patient referrals and in terms of investigation, follow-up and treatment. Those presenting with OA are more likely to be older and male, whereas those presenting with other diagnoses are more likely to be younger and female. Given the absence of high-quality evidence relating to common wrist disorders, this study points to the importance of generating high-quality evidence in order to guide practice in this area better, particularly in relationship to wrist OA.

Acknowledgements

All authors have made substantial contributions to all three of sections (1), (2) and (3): (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be submitted.

Funding: No funding has been received for this work.

Disclosure statement: The authors have declared no conflicts of interest.

Supplementary data

Supplementary data are available at Rheumatology online.

Supplementary Material

rkaa030_Supplementary_Data

Contributor Information

The MOWP study group::

Benjamin J F Dean, Andrew Carr, Ryan W Trickett, Stefan Kluzek, Nicholas Riley, Christopher P Bretherton, Melanie K Wilson, Mike J Hayton, Neal R Rupani, Ching Cheng Daniel Hsieh, Laura J Clifton, Peter Dacombe, Lydia K Milnes, Raveen L Jayasuriya, Harvey A George, Rishi Das, Alistair Mayne, Matthew T Brown, Stephen J Lipscombe, Gillian L Eastwood, Richard M Unsworth, Lucie J Wright, and Mohammed As-Sultany

References

  • 1. Jordan KP, Kadam UT, Hayward R. et al. Annual consultation prevalence of regional musculoskeletal problems in primary care: an observational study. BMC Musculoskelet Disord 2010;11:144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Walker-Bone K, Palmer KT, Reading I, Coggon D, Cooper C. Prevalence and impact of musculoskeletal disorders of the upper limb in the general population. Arthritis Rheum 2004;51:642–51. [DOI] [PubMed] [Google Scholar]
  • 3. Ferguson R, Riley ND, Wijendra A. et al. Wrist pain: a systematic review of prevalence and risk factors—what is the role of occupation and activity? BMC Musculoskelet Disord 2019;20:542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Dziedzic KS, Allen KD. Challenges and controversies of complex interventions in osteoarthritis management: recognizing inappropriate and discordant care. Rheumatology 2018;57:iv88–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Ammori MB, Elvey M, Mahmoud SS. et al. The outcome of bone graft surgery for nonunion of fractures of the scaphoid. J Hand Surg 2019;44:676–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Kawamura K, Chung KC. Treatment of scaphoid fractures and nonunions. J Hand Surg 2008;33:988–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957;16:494–502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. van Saase JL, van Romunde LK, Cats A, Vandenbroucke JP, Valkenburg HA. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis 1989;48:271–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Iordache SD, Rowan R, Garvin GJ. et al. Prevalence of triangular fibrocartilage complex abnormalities on MRI scans of asymptomatic wrists. J Hand Surg 2012;37:98–103. [DOI] [PubMed] [Google Scholar]
  • 10. Thornton AL, McCarty CW, Burgess MJ. Effectiveness of low-level laser therapy combined with an exercise program to reduce pain and increase function in adults with shoulder pain: a critically appraised topic. J Sport Rehabil 2013;22:72–8. [DOI] [PubMed] [Google Scholar]
  • 11. Lowden CM, Attiah M, Garvin G. et al. The prevalence of wrist ganglia in an asymptomatic population: magnetic resonance evaluation. J Hand Surg 2005;30:302–6. [DOI] [PubMed] [Google Scholar]
  • 12. Burgess RA, Pavlosky WF, Thompson RT. MRI-identified abnormalities and wrist range of motion in asymptomatic versus symptomatic computer users. BMC Musculoskelet Disord 2010;11:273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Chan SW, Tulloch E, Cooper ES. et al. Montgomery and informed consent: where are we now? BMJ 2017;357:j2224. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

rkaa030_Supplementary_Data

Articles from Rheumatology Advances in Practice are provided here courtesy of Oxford University Press

RESOURCES